Skip to content

Welcome to Discover Pharma! Today is : October 22, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Drug Delivery

  • Advanced Therapies,Clinical & Regulatory,Drug Delivery & Formulation,Pharmaceuticals and therapeutics,Research & Development,Therapeutic Areas

    Trixeo approved in EU for asthma

    AstraZeneca’s Trixeo has been approved in the EU as a [...]

    September 30, 2026
  • Clinical & Regulatory,Drug Delivery & Formulation,Pharmaceuticals and therapeutics,Therapeutic Areas

    EURneffy recommended for emergency anaphylaxis treatment in NHS Wales

    ALK’s 2mg nasal adrenaline spray has been recommended for use [...]

    September 16, 2026
  • Drug Delivery & Formulation,Manufacturing & Supply Chain,Research & Development

    Evonik invests €93M in new GMP LNP manufacturing facility

    Evonik is investing more than €93m in a new GMP [...]

    September 14, 2026
  • Clinical & Regulatory,Drug Delivery & Formulation,Pharmaceuticals and therapeutics,Research & Development

    FDA allows Medicus Pharma to start SkinJect study in patients with Gorlin Syndrome

    Medicus Pharma has received FDA clearance to begin a Phase [...]

    July 28, 2026
  • Advanced Therapies,Biotech & Pharma Business,Drug Delivery & Formulation,Manufacturing & Supply Chain,Pharmaceuticals and therapeutics

    Lonza expands ADC drug product capacity in Switzerland

    Lonza is expanding its commercial-scale aseptic drug product capacity in [...]

    July 23, 2026
  • Clinical & Regulatory,Drug Delivery & Formulation,Pharmaceuticals and therapeutics,Research & Development

    Rani reports positive Phase 1 data for oral obesity therapy RT-114

    Rani Therapeutics has reported positive initial Phase 1a data for [...]

    July 16, 2026
  • Clinical & Regulatory,Drug Delivery & Formulation,Drug Discovery & Development,Pharmaceuticals and therapeutics,Research & Development

    Healome raises £2M to advance eye-drop technology for ocular surface diseases

    Healome Therapeutics has raised £2 million in seed funding to [...]

    July 8, 2026
  • Advanced Therapies,Biotech & Pharma Business,Drug Delivery & Formulation

    Vect-Horus and Servier partner on targeted oligonucleotide therapies for rare CNS diseases

    Vect-Horus has entered a research collaboration and exclusive licence option [...]

    July 3, 2026
  • Advanced Therapies,Biotech & Pharma Business,Drug Discovery & Development

    Lonza acquires Nona blood-brain barrier technology for CNS therapies

    Lonza has acquired the rights to Nona Biosciences’ transferrin receptor [...]

    July 3, 2026
  • Drug Delivery & Formulation

    Lubrizol excipient recognised at CPhI China Pharma Excipients Awards

    Lubrizol’s Apisolex polymer has received a Silver award at the [...]

    June 19, 2026
12Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • E2 secures FDA clearance for pulmonary embolism thrombectomy system
    Categories: Clinical & Regulatory, Medical devices
  • Carterra and AstraZeneca target AI-driven drug discovery
    Categories: Biotech & Pharma Business, Digital & Data, Drug Discovery & Development, Research & Development
  • Biopharma dealmaking outlook improves despite investor caution
    Categories: Biotech & Pharma Business, Research & Development
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details.
OK
Go to Top